Literature DB >> 22723007

New perspectives on embryo biopsy: not how, but when and why?

Kangpu Xu1, Markus Montag.   

Abstract

During the past 2 decades, biopsy for preimplantation genetic diagnosis at three stages, that is, before conception (the first polar body), after fertilization (the second polar body), and early cleavage (D3 blastomeres) or blastocyst stage (D5/D6 trophectoderm biopsy), have been optimized and performed clinically in hundreds of in vitro fertilization centers around the world. Although opening the zona pellucida by mechanical or chemical means is still effectively in use, noncontact laser has become the indispensable instrument. Overall, the invasive nature of biopsy at any given stage is recognized. It is believed that removal of the polar bodies from M-II oocytes and fertilized zygotes may have the least detrimental effects on subsequent embryonic development; hence increasing applications of polar body biopsy are anticipated. Although D3 biopsy is currently the most frequently used method, the effectiveness of D3 cleavage-stage biopsy is unsettling because of the mosaicism in early cleavage human embryos. Controversies exist in several areas; particularly, the efficacy of preimplantation genetic screening based on one cell removed from a D3 embryo remains to be confirmed. With new genetic testing technology, there may be no need to biopsy two cells because accuracy from one cell is high and the risk of misdiagnosis is very low when sufficient markers are used for chromosome copy number assessment or for mutation detection of single-gene disorders. And finally, it appears that limited harm is caused by biopsy at the blastocyst stage and mosaicism seems to be less common as compared with earlier stages. Therefore, use of the blastocyst-stage biopsy combined with cryopreservation protocol can be effectively used for several indications. Furthermore, faster genetic analytical methods that can be completed within several hours will make this strategy more practical and attractive as fresh embryo transfer is possible. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 22723007     DOI: 10.1055/s-0032-1313905

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  9 in total

1.  Blastomere biopsy for PGD delays embryo compaction and blastulation: a time-lapse microscopic analysis.

Authors:  Liron Bar-El; Yael Kalma; Mira Malcov; Tamar Schwartz; Shaul Raviv; Tania Cohen; Hadar Amir; Yoni Cohen; Adi Reches; Ami Amit; Dalit Ben-Yosef
Journal:  J Assist Reprod Genet       Date:  2016-10-01       Impact factor: 3.412

Review 2.  Preimplantation genetic diagnosis guided by single-cell genomics.

Authors:  Niels Van der Aa; Masoud Zamani Esteki; Joris R Vermeesch; Thierry Voet
Journal:  Genome Med       Date:  2013-08-19       Impact factor: 11.117

3.  Live births after polar body biopsy and frozen-thawed cleavage stage embryo transfer: case report.

Authors:  Fernando Guimarães; Matheus Roque; Marcello Valle; Alessandra Kostolias; Rodrigo A de Azevedo; Ciro D Martinhago; Marcos Sampaio; Selmo Geber
Journal:  JBRA Assist Reprod       Date:  2016-12-01

4.  Number of blastocysts biopsied as a predictive indicator to obtain at least one normal/balanced embryo following preimplantation genetic diagnosis with single nucleotide polymorphism microarray in translocation cases.

Authors:  Yi-Zi Wang; Chen-Hui Ding; Jing Wang; Yan-Hong Zeng; Wen Zhou; Rong Li; Can-Quan Zhou; Ming-Fen Deng; Yan-Wen Xu
Journal:  J Assist Reprod Genet       Date:  2016-11-07       Impact factor: 3.412

Review 5.  From Prenatal to Preimplantation Genetic Diagnosis of β-Thalassemia. Prevention Model in 8748 Cases: 40 Years of Single Center Experience.

Authors:  Giovanni Monni; Cristina Peddes; Ambra Iuculano; Rosa Maria Ibba
Journal:  J Clin Med       Date:  2018-02-20       Impact factor: 4.241

6.  Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology.

Authors:  Joyce C Harper; Joep Geraedts; Pascal Borry; Martina C Cornel; Wybo Dondorp; Luca Gianaroli; Gary Harton; Tanya Milachich; Helena Kääriäinen; Inge Liebaers; Michael Morris; Jorge Sequeiros; Karen Sermon; Françoise Shenfield; Heather Skirton; Sirpa Soini; Claudia Spits; Anna Veiga; Joris Robert Vermeesch; Stéphane Viville; Guido de Wert; Milan Macek
Journal:  Eur J Hum Genet       Date:  2013-11       Impact factor: 4.246

7.  Biopsy of human morula-stage embryos: outcome of 215 IVF/ICSI cycles with PGS.

Authors:  Elena E Zakharova; Victoria V Zaletova; Alexander S Krivokharchenko
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

8.  Impact of whole-genome amplification on the reliability of pre-transfer cattle embryo breeding value estimates.

Authors:  Habib A Shojaei Saadi; Christian Vigneault; Mehdi Sargolzaei; Dominic Gagné; Éric Fournier; Béatrice de Montera; Jacques Chesnais; Patrick Blondin; Claude Robert
Journal:  BMC Genomics       Date:  2014-10-12       Impact factor: 3.969

9.  High-efficiency derivation of human embryonic stem cell lines using a culture system with minimized trophoblast cell proliferation.

Authors:  Chuti Laowtammathron; Pimjai Chingsuwanrote; Roungsin Choavaratana; Suphadtra Phornwilardsiri; Ketsara Sitthirit; Chidchanok Kaewjunun; Orawan Makemaharn; Papussorn Terbto; Supaporn Waeteekul; Chanchao Lorthongpanich; Yaowalak U-Pratya; Pimonwan Srisook; Pakpoom Kheolamai; Surapol Issaragrisil
Journal:  Stem Cell Res Ther       Date:  2018-05-11       Impact factor: 6.832

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.